Why Is Vistagen Therapeutics (VTGN) Stock Up 650% Today?

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

Vistagen Therapeutics has reported positive Phase 3 trial results for a social anxiety treatment. VTGN stock is skyrocketing as a result.

The post Why Is Vistagen Therapeutics (VTGN) Stock Up 650% Today? appeared first on InvestorPlace.

• ChatGPT IPO Could Shock the World, Make This Move Before the Announcement
• Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In.
• The $1 Investment You MUST Take Advantage of Right Now
• The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors